LCM
DMK

Leisure Capital Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Leisure Capital Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-319
Closed -$29K – 121
2019
Q2 		$29K Sell
319
-1,334
-81% -$162K 0.03% 113
2019
Q1 		$244K Buy
1,653
+71
+4% +$13.7K 0.21% 107
2018
Q4 		$249K Sell
1,582
-146
-8% -$28K 0.23% 109
2018
Q3 		$423K Sell
1,728
-519
-23% -$123K 0.34% 104
2018
Q2 		$503K Buy
2,247
+191
+9% +$51.1K 0.43% 95
2018
Q1 		$504K Sell
2,056
-38
-2% -$9.97K 0.44% 63
2017
Q4 		$645K Buy
2,094
+46
+2% +$15.1K 0.54% 57
2017
Q3 		$749K Sell
2,048
-36
-2% -$12.8K 0.66% 52
2017
Q2 		$759K Buy
2,084
+140
+7% +$41.9K 0.68% 46
2017
Q1 		$578K Sell
1,944
-52
-3% -$13.1K 0.51% 54
2016
Q4 		$440K Buy
1,996
+37
+2% +$7.42K 0.4% 65
2016
Q3 		$470K Buy
+1,959
New +$407K 0.44% 58

Other funds holding DMK

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Leisure Capital Management's DMK Position: Q3 2019 in Review

Leisure Capital Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2019, closing a stake of 319 shares — an estimated $29K sold.

Leisure Capital Management first reported a position in DMK in Q3 2016 and held it in 12 quarters. The position peaked at $759K in Q2 2017. 50 funds tracked by Wall St. Rank hold DMK as of Q3 2019.

  • Leisure Capital Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2019 after selling out during the quarter.
  • Leisure Capital Management sold 319 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2019, an estimated $29K.
  • Leisure Capital Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2016 and held it in 12 quarters.
  • Leisure Capital Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $759K in Q2 2017.
  • 50 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2019.

Based on Leisure Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.